Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status
about
PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancerMultifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: epidemiological and clinical data from a population-based cancer registry study.Effect of central nervous system metastases on treatment discontinuation and survival in older women receiving trastuzumab for metastatic breast cancer.Metastasis: recent discoveries and novel treatment strategies.Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients.Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detection.Revisiting the role of molecular targeted therapies in patients with brain metastases.Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update.Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment.Predictive factors of brain metastasis in patients with breast cancer.Changes in medical oncology admissions for the management of breast cancer complications: an Australian institution's experience.Brain metastases in HER2-positive metastatic breast cancer patients who received chemotherapy with or without trastuzumab.
P2860
Q27006181-911F7155-1231-46FC-9B31-32A8EBACF1A0Q33878643-933E816E-9727-4FA6-8B38-21ADF0375DAFQ35909243-CE571028-9282-453E-8B91-885B020DF965Q36407511-686665C2-7EDE-4FED-9110-8A77663B3210Q37141921-12F653FC-CED7-403D-BF72-E14196A34B6AQ37199601-AD28F58E-F57E-4D70-9ED8-95E37388F64DQ37904792-BD67DAF9-50A6-4F23-B3C3-C6A6E883FA37Q38230553-6B5F6F1A-F0A6-4A63-95B1-4CFA89250A17Q44417765-A538F5D1-9A52-4476-AC8C-DC7B1280735CQ45771188-F533C910-D808-4365-B802-760693323A2AQ51164112-D9C8C6D4-6795-4360-AD92-773806D9A3FCQ54386974-99DEEE1C-2AA8-44DA-8C13-95A1A269BB4F
P2860
Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Central nervous system relapse ...... s and with the HER2/neu status
@ast
Central nervous system relapse ...... s and with the HER2/neu status
@en
type
label
Central nervous system relapse ...... s and with the HER2/neu status
@ast
Central nervous system relapse ...... s and with the HER2/neu status
@en
prefLabel
Central nervous system relapse ...... s and with the HER2/neu status
@ast
Central nervous system relapse ...... s and with the HER2/neu status
@en
P2093
P2860
P356
P1476
Central nervous system relapse ...... s and with the HER2/neu status
@en
P2093
Athanasios Pallis
Charalambos Kouroussis
Dimitris Mavroudis
Georgia Millaki
Irine Kazakou
John Souglakos
Kostas Kalbakis
Lambros Vamvakas
Maria Perraki
Nikos Androulakis
P2860
P2888
P356
10.1186/BCR1516
P577
2006-01-01T00:00:00Z
P5875
P6179
1016896653